Healthcare -
Biotechnology - NASDAQ - US
$ 20.6
1.73 %
$ 3.5 B
Market Cap
-7.86
P/E
IMVT - OPERATING EXPENSES
Operating Expenses IMVT - Immunovant, Inc.
283 M
LAST VALUE
34.61%
2 YEAR CAGR
1345.48%
5 YEAR CAGR
0.00%
10 YEAR CAGR